HERON THERAPEUTICS, INC. /DE/ Logo

HERON THERAPEUTICS, INC. /DE/

Develops and commercializes therapies for acute care and oncology to manage pain and nausea.

HRTX | US

Overview

Corporate Details

ISIN(s):
US4277461020
LEI:
Country:
United States of America
Address:
4242 CAMPUS POINT COURT, SUITE 200, 92121 SAN DIEGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving patient outcomes by developing and commercializing therapies in acute care and oncology. The company leverages its proprietary science and technology to create best-in-class medicines that address unmet medical needs. Its portfolio of FDA-approved products includes ZYNRELEF® for postoperative pain management, APONVIE® for postoperative nausea and vomiting (PONV), and both CINVANTI® and SUSTOL® for the prevention of chemotherapy-induced nausea and vomiting (CINV). Heron's strategy involves applying innovative drug delivery technologies to well-known pharmacological agents to enhance their therapeutic benefit and advance the standard of care.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HERON THERAPEUTICS, INC. /DE/ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HERON THERAPEUTICS, INC. /DE/

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HERON THERAPEUTICS, INC. /DE/ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden
2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom
4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops medicines for tropical diseases, including ARAKODA for malaria prevention.
United States of America
SXTP
89bio, Inc. Logo
Developing therapies for liver and cardiometabolic diseases like MASH and SHTG.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Developing oral drugs to suppress appetite for obesity and rare metabolic diseases.
United States of America
AARD
AbbVie Inc. Logo
A research-based biopharma firm creating medicines for immunology, oncology, and neuroscience.
United States of America
ABBV
ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden
ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX

Talk to a Data Expert

Have a question? We'll get back to you promptly.